Effect of reduced dietary fat on estradiol, adiponectin, and IGF-1 levels in postmenopausal women with breast cancer

Blanca Murillo-Ortiz,1 Sandra Martínez-Garza,1 Vanessa Cárdenas Landeros,1 Gerardo Cano Velázquez,1 David Suárez García2 1Clinical Epidemiology Research Unit, 2Department of Oncology, Mexican Institute of Social Security, Leon, Mexico I...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Murillo-Ortiz B, Martínez-Garza S, Cárdenas Landeros V, Cano Velázquez G, Suárez Garci­a D
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2017
Materias:
BMI
Acceso en línea:https://doaj.org/article/f52d325fea3f413fb69d767f0c123959
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f52d325fea3f413fb69d767f0c123959
record_format dspace
spelling oai:doaj.org-article:f52d325fea3f413fb69d767f0c1239592021-12-02T02:03:37ZEffect of reduced dietary fat on estradiol, adiponectin, and IGF-1 levels in postmenopausal women with breast cancer1179-1314https://doaj.org/article/f52d325fea3f413fb69d767f0c1239592017-05-01T00:00:00Zhttps://www.dovepress.com/effect-of-reduced-dietary-fat-on-estradiol-adiponectin-and-igf-1-level-peer-reviewed-article-BCTThttps://doaj.org/toc/1179-1314Blanca Murillo-Ortiz,1 Sandra Martínez-Garza,1 Vanessa Cárdenas Landeros,1 Gerardo Cano Velázquez,1 David Suárez García2 1Clinical Epidemiology Research Unit, 2Department of Oncology, Mexican Institute of Social Security, Leon, Mexico Introduction: In recent years, epidemiological studies have strongly related obesity with an increased risk of developing postmenopausal breast cancer. The aromatization of fatty tissue increases the levels of estradiol and adiponectin, which is correlated with the body mass index (BMI). It is of interest to investigate the effect of reducing BMI on estradiol, adiponectin, and IGF-1, as reducing BMI could be a new strategy to limit the risk of recurrence during the adjuvant treatment of breast cancer.Objective: The aim of this study is to investigate the effect of reduced dietary fat on the levels of serum estradiol, adiponectin, and IGF-1 among postmenopausal Mexican women with breast cancer.Methods: In this controlled clinical trial, 100 female patients were randomly divided into two groups and followed for six months. Group 1 (n = 50) was subjected to reduced dietary fat, whereas Group 2 (n = 50) was subjected to a control diet. The levels of serum estradiol and testosterone were determined using an enzyme-linked immunosorbent assay, whereas the concentrations of adiponectin and IGF-1 were determined using a radioimmunoassay.Results: The patients subjected to reduced dietary fat showed a significant difference in BMI (27.93 ± 4.45 vs 26.05 ± 2.65; p = 0.01) and waist circumference (99.92 vs 91.59 cm; p = 0.0001) after the treatment. Moreover, a significant decrease in serum estradiol was observed (21.23 ± 14.32 vs 16.05 ± 10.25 ng/mL; p < 0.001). The adiponectin concentration also decreased significantly (47.53 ± 12.19 vs 42.52 ± 12.34 µg/mL; p = 0.004), while IGF-1 and testosterone did not show significant changes (p > 0.05). In addition, BMI had a relationship with serum adiponectin (r = −0.27; p = 0.02) and estradiol (r = 0.37; p = 0.001).Conclusion: The current study shows that reducing BMI decreases serum estradiol and adiponectin. Large clinical trials are needed to investigate the role of adiponectin in breast cancer development in obese women. Keywords: reduced dietary fat, breast cancer, hormone levelsMurillo-Ortiz BMartínez-Garza SCárdenas Landeros VCano Velázquez GSuárez Garci­a DDove Medical PressarticleBreast CancerBMIEstradiolAdiponectinIGF 1.Neoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENBreast Cancer: Targets and Therapy, Vol Volume 9, Pp 359-364 (2017)
institution DOAJ
collection DOAJ
language EN
topic Breast Cancer
BMI
Estradiol
Adiponectin
IGF 1.
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle Breast Cancer
BMI
Estradiol
Adiponectin
IGF 1.
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Murillo-Ortiz B
Martínez-Garza S
Cárdenas Landeros V
Cano Velázquez G
Suárez Garci­a D
Effect of reduced dietary fat on estradiol, adiponectin, and IGF-1 levels in postmenopausal women with breast cancer
description Blanca Murillo-Ortiz,1 Sandra Martínez-Garza,1 Vanessa Cárdenas Landeros,1 Gerardo Cano Velázquez,1 David Suárez García2 1Clinical Epidemiology Research Unit, 2Department of Oncology, Mexican Institute of Social Security, Leon, Mexico Introduction: In recent years, epidemiological studies have strongly related obesity with an increased risk of developing postmenopausal breast cancer. The aromatization of fatty tissue increases the levels of estradiol and adiponectin, which is correlated with the body mass index (BMI). It is of interest to investigate the effect of reducing BMI on estradiol, adiponectin, and IGF-1, as reducing BMI could be a new strategy to limit the risk of recurrence during the adjuvant treatment of breast cancer.Objective: The aim of this study is to investigate the effect of reduced dietary fat on the levels of serum estradiol, adiponectin, and IGF-1 among postmenopausal Mexican women with breast cancer.Methods: In this controlled clinical trial, 100 female patients were randomly divided into two groups and followed for six months. Group 1 (n = 50) was subjected to reduced dietary fat, whereas Group 2 (n = 50) was subjected to a control diet. The levels of serum estradiol and testosterone were determined using an enzyme-linked immunosorbent assay, whereas the concentrations of adiponectin and IGF-1 were determined using a radioimmunoassay.Results: The patients subjected to reduced dietary fat showed a significant difference in BMI (27.93 ± 4.45 vs 26.05 ± 2.65; p = 0.01) and waist circumference (99.92 vs 91.59 cm; p = 0.0001) after the treatment. Moreover, a significant decrease in serum estradiol was observed (21.23 ± 14.32 vs 16.05 ± 10.25 ng/mL; p < 0.001). The adiponectin concentration also decreased significantly (47.53 ± 12.19 vs 42.52 ± 12.34 µg/mL; p = 0.004), while IGF-1 and testosterone did not show significant changes (p > 0.05). In addition, BMI had a relationship with serum adiponectin (r = −0.27; p = 0.02) and estradiol (r = 0.37; p = 0.001).Conclusion: The current study shows that reducing BMI decreases serum estradiol and adiponectin. Large clinical trials are needed to investigate the role of adiponectin in breast cancer development in obese women. Keywords: reduced dietary fat, breast cancer, hormone levels
format article
author Murillo-Ortiz B
Martínez-Garza S
Cárdenas Landeros V
Cano Velázquez G
Suárez Garci­a D
author_facet Murillo-Ortiz B
Martínez-Garza S
Cárdenas Landeros V
Cano Velázquez G
Suárez Garci­a D
author_sort Murillo-Ortiz B
title Effect of reduced dietary fat on estradiol, adiponectin, and IGF-1 levels in postmenopausal women with breast cancer
title_short Effect of reduced dietary fat on estradiol, adiponectin, and IGF-1 levels in postmenopausal women with breast cancer
title_full Effect of reduced dietary fat on estradiol, adiponectin, and IGF-1 levels in postmenopausal women with breast cancer
title_fullStr Effect of reduced dietary fat on estradiol, adiponectin, and IGF-1 levels in postmenopausal women with breast cancer
title_full_unstemmed Effect of reduced dietary fat on estradiol, adiponectin, and IGF-1 levels in postmenopausal women with breast cancer
title_sort effect of reduced dietary fat on estradiol, adiponectin, and igf-1 levels in postmenopausal women with breast cancer
publisher Dove Medical Press
publishDate 2017
url https://doaj.org/article/f52d325fea3f413fb69d767f0c123959
work_keys_str_mv AT murilloortizb effectofreduceddietaryfatonestradioladiponectinandigf1levelsinpostmenopausalwomenwithbreastcancer
AT martinezgarzas effectofreduceddietaryfatonestradioladiponectinandigf1levelsinpostmenopausalwomenwithbreastcancer
AT cardenaslanderosv effectofreduceddietaryfatonestradioladiponectinandigf1levelsinpostmenopausalwomenwithbreastcancer
AT canovelazquezg effectofreduceddietaryfatonestradioladiponectinandigf1levelsinpostmenopausalwomenwithbreastcancer
AT suarezgarciad effectofreduceddietaryfatonestradioladiponectinandigf1levelsinpostmenopausalwomenwithbreastcancer
_version_ 1718402748447195136